Novel mutations target distinct subgroups of medulloblastomaGiles Robinson, Richard J. Gilbertson, Timothy N. Phoenix et al.|Nature|2012Cited by 853
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium studySri Gururangan, L. Kun, Jason Fangusaro et al.|Neuro-Oncology|2012Cited by 60
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A. Upadhyaya, Amar Gajjar, Olivia Campagne et al.|Neuro-Oncology|2022Cited by 29